
Current Price | $0.76 | Mkt Cap | $17.6M |
---|---|---|---|
Open | $0.77 | P/E Ratio | 0.00 |
Prev. Close | $0.76 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.71 - $0.78 | Volume | 150,560 |
52-Wk Range | $0.65 - $4.56 | Avg. Daily Vol. | 392,841 |
A biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.
Current Price | $0.76 | Mkt Cap | $17.6M |
---|---|---|---|
Open | $0.77 | P/E Ratio | 0.00 |
Prev. Close | $0.76 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.71 - $0.78 | Volume | 150,560 |
52-Wk Range | $0.65 - $4.56 | Avg. Daily Vol. | 392,841 |
The best Bull and Bear pitches based on recency and number of recommendations.
Cutting edge research being completed at Opexa, huge buyout potential here, one of those specs that could change how MS is treated. Balance sheet strong, low risk of secondary. Great risk reward, with over 500% upisde quite possible for long-term… More
Read the most recent pitches from players about ACER.
Recs
Uses known stock pump and dumper Redchip.com for PR purposes. Garbage.
Recs
One massive IHS on monhtly
Recs
Cutting edge research being completed at Opexa, huge buyout potential here, one of those specs that could change how MS is treated. Balance sheet strong, low risk of secondary. Great risk reward, with over 500% upisde quite possible for long-term holders in 2014.
Find the members with the highest scoring picks in ACER.
whatsthepoint (99.99) Score: +538.66
The Score Leader is the player with the highest score across all their picks in ACER.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
MaxPwr273 | 73.24 | 10/26/2011 |
![]() |
5Y | $364.50 | -99.79% | +218.08% | +317.87 | 0 Comment | |
2011Fool | 96.96 | 2/18/2011 |
![]() |
NS | $632.90 | -99.88% | +195.07% | +294.95 | 0 Comment | |
saab93boi | < 20 | 3/26/2013 |
![]() |
3W | $211.24 | -99.64% | +154.05% | +253.69 | 0 Comment | |
stockjock11 | < 20 | 5/22/2013 |
![]() |
5Y | $138.34 | -99.45% | +135.28% | +234.73 | 0 Comment | |
allstar31 | 99.93 | 9/15/2014 |
![]() |
5Y | $111.01 | -99.32% | +99.08% | +198.40 | 1 Comment | |
zzlangerhans | 99.73 | 10/31/2016 |
![]() |
1Y | $8.80 | -91.39% | +86.53% | +177.92 | 0 Comment | |
warrenout2 | 95.37 | 11/14/2016 |
![]() |
5Y | $6.06 | -87.49% | +82.69% | +170.18 | 0 Comment | |
warrenout | 30.20 | 11/16/2016 |
![]() |
5Y | $5.87 | -87.10% | +82.24% | +169.34 | 0 Comment | |
tsperbeck | 98.35 | 2/3/2017 |
![]() |
5Y | $10.44 | -92.74% | +72.92% | +165.66 | 0 Comment | |
johnnyrocku | 99.94 | 10/16/2017 |
![]() |
5Y | $18.69 | -95.94% | +55.48% | +151.43 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.